Summary

Eligibility
for people ages 18 years and up (full criteria)
Healthy Volunteers
healthy people welcome
Location
at UCSD
Dates
study started
completion around
Principal Investigator
by Stephen Spector, MD (ucsd)

Description

Summary

This is a prospective cohort study designed to define the impact of HIV infection and antiretroviral therapy (ART) on young adults with perinatal HIV infection (YAPHIV) as they transition into adulthood. A group of of perinatally exposed but uninfected young adults from a similar sociodemographic background and age distribution will be enrolled for comparison.

Details

Keywords

HIV/AIDS, HIV/AIDS, perinatal HIV infection, Acquired Immunodeficiency Syndrome, HIV Infections

Eligibility

Locations

  • University of California San Diego accepting new patients
    La Jolla California 92093 United States
  • University of Colorado Denver Health Sciences Center accepting new patients
    Aurora Colorado 80045 United States

Lead Scientist at University of California Health

  • Stephen Spector, MD (ucsd)
    Dr. Spector, a world leader in HIV research for more than 25 years, is Distinguished Professor of Pediatrics, the Chief of the Division of Pediatric Infectious Diseases and Director of the UCSD Mother-Child-Adolescent HIV Program.

Details

Status
accepting new patients
Start Date
Completion Date
(estimated)
Sponsor
Harvard School of Public Health (HSPH)
Links
Pediatric HIV/AIDS Cohort Study
ID
NCT02119702
Study Type
Observational
Participants
Expecting 820 study participants
Last Updated